Completed PHASE3 INTERVENTIONAL NCT00168532

Prophylactic Antibiotics in Measles

Prophylactic Antibiotics in Measles Infection. A Community-Based Randomised Double-Blind Placebo-Controlled Trial in Guinea-Bissau

Sponsor: Bandim Health Project

Conditions Measles Post-Measles Pneumonia

Interventions Sulfamethoxazole-Trimethoprim

Updated 6 times since 2017 Last updated: Feb 25, 2008 Started: Jan 31, 1998 Primary completion: Oct 31, 2001 Completion: Oct 31, 2001

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Measles and Post-Measles Pneumonia, this trial is completed. The trial is conducted by Bandim Health Project and has accumulated 6 data snapshots since 1998. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE3
Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jan 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bandim Health Project
Medical Research Council Unit, The Gambia

Data source: Bandim Health Project

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bissau, Guinea-Bissau